EFFICACY OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEMINHIBITORS AND BETA-BLOCKERS IN PATIENTS WITH ARTERIALHYPERTENSION AND THEIR INFLUENCE ON METABOLICSYNDROME
- Authors: Tarasov AV1, Maneshina OA1
-
Affiliations:
- Issue: Vol 5, No 1 (2008)
- Pages: 75-76
- Section: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/117963
- ID: 117963
Cite item
Full Text
Abstract
Treatment with renin-angiotensin-aldosterone system inhibitors not only produced a good antihypertensive effect but also
exerted a beneficial influence on metabolic syndrome and decreased the risk of cardiovascular death, while the use of betablocker
metoprolol was more frequently associated with development of metabolic syndrome and a less pronounced influence
on the risk of cardiovascular death.
exerted a beneficial influence on metabolic syndrome and decreased the risk of cardiovascular death, while the use of betablocker
metoprolol was more frequently associated with development of metabolic syndrome and a less pronounced influence
on the risk of cardiovascular death.
References
- Чазова И. Е. Метаболические и сосудистые эффекты антигипертензивной терапии. - М., 2005.
- Controy R. M., Pyorala K., Fitzgerald A. P., et al. // Eur Heart J. - 2003. - Vol. 24. - P. 987-1003.
- Isomaa B., Almgren P., Tuomi T., et al. // Diabetes Care. - 2001. - Vol. 24. - P. 683-689.
- WHO/ISH // J. Hypertens. - 1999. - Vol. 17. - P. 151- 183..
Supplementary files
